C1q as a unique player in angiogenesis with therapeutic implication in wound healing

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 11, 2014, Pages 4209-4214

  Bossi, Fleur ^a   Tripodo, Claudio ^b   Rizzi, Lucia ^a   Bulla, Roberta ^a   Agostinis, Chiara ^c   Guarnotta, Carla ^b   Munaut, Carine ^d   Baldassarre, Gustavo ^e   Papa, Giovanni ^f   Zorzet, Sonia ^a   Ghebrehiwet, Berhane ^g   Ling, Guang Sheng ^h   Botto, Marina ^h   Tedesco, Francesco ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^f UNIVERSITY OF TRIESTE   (Italy)

^g STONY BROOK UNIVERSITY   (United States)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Animal models; Complement; Vasculogenesis

Indexed keywords

COMPLEMENT COMPONENT C1Q;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GRANULATION TISSUE; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOPICAL TREATMENT; VASCULAR RING; WOUND HEALING;

ANIMAL MODELS; COMPLEMENT; VASCULOGENESIS;

ANIMALS; CELL PROLIFERATION; COMPLEMENT C1Q; DNA PRIMERS; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; WOUND HEALING;

EID: 84896529758     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1311968111     Document Type: Article

References (27)

1. Folkman J (2003) Fundamental concepts of the angiogenic process. Curr Mol Med 3(7):643-651. (Pubitemid 37236406)
2. Sato Y (2012) The vasohibin family: Novel regulators of angiogenesis. Vascul Pharmacol 56(5-6):262-266.
3. Raza A, Franklin MJ, Dudek AZ (2010) Pericytes and vessel maturation during tumor angiogenesis and metastasis. Am J Hematol 85(8):593-598.
4. Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438(7070): 932-936. (Pubitemid 43093958)
5. Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/ vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146(5):1029-1039.
6. Chung AS, Ferrara N (2011) Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol 27:563-584.
7. Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473(7347):298-307.
8. Semenza GL (2007) Vasculogenesis, angiogenesis, and arteriogenesis: Mechanisms of blood vessel formation and remodeling. J Cell Biochem 102(4):840-847. (Pubitemid 350036924)
9. Fischetti F, Tedesco F (2006) Cross-talk between the complement system and endothelial cells in physiologic conditions and in vascular diseases. Autoimmunity 39(5):417-428. (Pubitemid 44269620)
10. Johnson LV, Leitner WP, Staples MK, Anderson DH (2001) Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp Eye Res 73(6):887-896. (Pubitemid 34112114)
11. Nozaki M, et al. (2006) Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci USA 103(7):2328-2333. (Pubitemid 43271669)
12. Bora PS, et al. (2005) Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. J Immunol 174(1):491-497. (Pubitemid 40007439)
13. Bora NS, et al. (2006) Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: Role of factor B and factor H. J Immunol 177(3):1872-1878. (Pubitemid 44092526)
14. Bora NS, et al. (2007) CD59, a complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degeneration. J Immunol 178(3):1783-1790. (Pubitemid 46154650)
15. Langer HF, et al. (2010) Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis. Blood 116(22):4395-4403.
16. Nayak A, Pednekar L, Reid KB, Kishore U (2012) Complement and non-complement activating functions of C1q: A prototypical innate immune molecule. Innate Immun 18(2):350-363.
17. Nayak A, Ferluga J, Tsolaki AG, Kishore U (2010) The non-classical functions of the classical complement pathway recognition subcomponent C1q. Immunol Lett 131(2): 139-150.
18. Feng X, Tonnesen MG, Peerschke EI, Ghebrehiwet B (2002) Cooperation of C1q receptors and integrins in C1q-mediated endothelial cell adhesion and spreading. J Immunol 168(5):2441-2448. (Pubitemid 34171848)
19. van den Berg RH, Faber-Krol MC, Sim RB, Daha MR (1998) The first subcomponent of complement, C1q, triggers the production of IL-8, IL-6, and monocyte chemoattractant peptide-1 by human umbilical vein endothelial cells. J Immunol 161(12):6924-6930. (Pubitemid 28562239)
20. Navratil JS, Watkins SC, Wisnieski JJ, Ahearn JM (2001) The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells. J Immunol 166(5):3231-3239. (Pubitemid 33117322)
21. Benoit ME, Tenner AJ (2011) Complement protein C1q-mediated neuroprotection is correlated with regulation of neuronal gene and microRNA expression. J Neurosci 31(9):3459-3469.
22. Bulla R, et al. (2008) Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium. Mol Immunol 45(9):2629-2640.
23. Kevil CG, Payne DK, Mire E, Alexander JS (1998) Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins. J Biol Chem 273(24):15099-15103. (Pubitemid 28272806)
24. Dvorak HF (1986) Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315(26):1650-1659. (Pubitemid 17052899)
25. Kurihara R, et al. (2010) C5a promotes migration, proliferation, and vessel formation in endothelial cells. Inflamm Res 59(8):659-666.
26. Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE (2006) Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med 203(9):2165-2175. (Pubitemid 44352237)
27. Lee RJ, et al. (2000) VEGF gene delivery to myocardium: Deleterious effects of unregulated expression. Circulation 102(8):898-901.